Merck KGaA
看多

Bioreactor markets running at 20% CAGR

71
Was researching the bio reactor space following the recent results of Sartorius and found that they three key players are Merck, Sartorius and TMO. Definitely not cheap, but the cheapest among peers, with solid fundamentals. A trade to watch out in dips.

免責聲明

這些資訊和出版物並非旨在提供,也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。